Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach.
Even AJ, Hamming-Vrieze O, van Elmpt W, Winnepenninckx VJ, Heukelom J, Tesselaar ME, Vogel WV, Hoeben A, Zegers CM, Vugts DJ, van Dongen GA, Bartelink H, Mottaghy FM, Hoebers F, Lambin P.
Even AJ, et al. Among authors: van elmpt w, van dongen ga.
Oncotarget. 2017 Jan 17;8(3):3870-3880. doi: 10.18632/oncotarget.13910.
Oncotarget. 2017.
PMID: 27965472
Free PMC article.